EPO Patents = 4

Trademarks = 2

Forward Citations = 1

Loading Chart...

7 inventors (with patents filed for the assignee):

Charlie Galle (3 out of 3 patents)

Joël Chavas (2 out of 3 patents)

Guillaume Chenegros (2 out of 10 patents)

4. Francesco Galluppi (2 out of 2 patents)

5. Benjamin R Benosman (1 out of 3 patents)

6. Guillaume Chenegros (3 patents)

7. Benjamin Benosman (0 patent)

5 patents: Sort by Forward Citations

1. 12364875 - Viewing apparatus and method for projecting a light signal (2025-07-22),

2. 11986668 - Method for controlling an optogenetic device using filtering and associated devices (2024-05-21),

3. 11875545 - Method and device for processing asynchronous signals generated by an event-based light sensor (2024-01-16),

4. 11400311 - Device for illuminating an object with a controlled light intensity and associated method (2022-08-02),

5. 11320649 - Objective, camera and system adapted for optogenetics comprising such objective (2022-05-03),

Gensight Biologics is a biotechnology company focused on developing gene therapies for the treatment of genetic diseases affecting the eyes. The company's lead product candidate, GS010, is a gene therapy designed to treat Leber's hereditary optic neuropathy. Gensight Biologics is dedicated to advancing innovative treatments for patients with inherited retinal and neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#531 in Paris

#2,811 in France

Paris, France

Gensight Biologics